Bosh sahifaDC4 • ETR
add
DexCom Inc
Yopilish kursi
71,18 €
Kunlik diapazon
71,47 € - 72,31 €
Yillik diapazon
51,62 € - 121,80 €
Bozor kapitalizatsiyasi
31,47 mlrd USD
Oʻrtacha hajm
376,00
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 1,04 mlrd | 12,49% |
Joriy xarajat | 455,30 mln | -1,19% |
Sof foyda | 105,40 mln | -28,01% |
Sof foyda marjasi | 10,17 | -36,04% |
Har bir ulushga tushum | 0,32 | 0,00% |
EBITDA | 193,70 mln | 26,11% |
Amaldagi soliq stavkasi | 31,69% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 2,70 mlrd | -6,75% |
Jami aktivlari | 6,75 mlrd | 4,16% |
Jami passivlari | 4,49 mlrd | 5,90% |
Umumiy kapital | 2,27 mlrd | — |
Tarqatilgan aksiyalar | 392,11 mln | — |
Narxi/balansdagi bahosi | 12,31 | — |
Aktivlardan daromad | 5,05% | — |
Kapitaldan daromad | 7,00% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 105,40 mln | -28,01% |
Operatsiyalardan naqd pul | 183,80 mln | -12,14% |
Sarmoyadan naqd pul | 100,20 mln | 33,96% |
Moliyadan naqd pul | 12,50 mln | 165,96% |
Naqd pulning sof oʻzgarishi | 298,80 mln | 4,88% |
Boʻsh pul | 67,92 mln | -39,14% |
Haqida
DexCom, Inc. is an American healthcare company that develops, manufactures, produces, and distributes a line of continuous glucose monitoring systems for diabetes management. It operates internationally with headquarters in San Diego, California; and has manufacturing facilities in Mesa, Arizona; Batu Kawan, Malaysia; and Athenry, Ireland. Wikipedia
Tashkil etilgan
1999
Xodimlar soni
10 250
